- Joined
- 2 June 2011
- Posts
- 5,341
- Reactions
- 242
Many years ago I had them in my head as a niche manufacturer somewhat related to the buildings supply game... they then tried to reposition themselves as a health tech company (why?) and then god knows what they do now.
It's probably a good business management case study on how to shrink to crap-ness.
That's what I had them pegged as. Now it's very hard to know what they do. Sort of like throw enough **** at a wall and hope some of it sticks.
Ves said:I love the investor presentation.
"Excluding the restructure provisions payments, net cash flow generated by operating activities would have been $8.1 million in 1HFY16...."
I only skimmed over the prezo when it came out, too busy to spend too much time on mediocre companies at that time of year. The things that surprised was they said the share price decline is what triggered the review of asset values. Since when is that the way accountants review carrying values?